Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Observational Study on Evaluation of Glycaemic Control in Patients Using a Modern Insulin - NovoRapid® (Insulin Aspart), NovoMix® 30 (Biphasic Insulin Aspart 30) or Levemir® (Insulin Detemir) for Treatment of Type 2 Diabetes Mellitus

This study is conducted in Europe. An observational study evaluating the blood glucose control in patients using a modern insulin: NovoRapid®, NovoMix® 30 or Levemir® for treatment of Type 2 diabetes mellitus in Czech Republic.

Inclusion Criteria:

• Type 2 diabetes
• Current treatment with human soluble insulin, insulin NPH or premixed human insulin
• The selection of the subjects will be at the discretion of the individual physician

Exclusion Criteria:

• Current treatment with insulin aspart, insulin detemir or biphasic insulin aspart 30
• Previous enrolment in this study
• Hypersensitivity to insulin aspart, insulin detemir or biphasic insulin aspart 30 or to any of the excipients.
• Women who are pregnant, breast feeding or have the intention of becoming pregnant within next 6 months and considered to be treated by biphasic insulin aspart 30 or insulin detemir